11.90
price up icon1.28%   0.15
after-market Dopo l'orario di chiusura: 11.90
loading

Stoke Therapeutics Inc Borsa (STOK) Ultime notizie

pulisher
04:30 AM

Stoke Therapeutics Appoints Chief People Officer: 260,000 Share Options Grant Reveals Aggressive Retention Strategy - Stock Titan

04:30 AM
pulisher
02:13 AM

Analysts Are Bullish on Top Healthcare Stocks: Eli Lilly & Co (LLY), Stoke Therapeutics (STOK) - The Globe and Mail

02:13 AM
pulisher
Jul 15, 2025

How Stoke Therapeutics Inc. stock performs during market volatilityProven Trading Plan - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Stoke Therapeutics Inc. stock price move sharplyDaily Price Surge List - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Stoke Therapeutics Inc. stock attracts strong analyst attentionHigh Potential Stock Ideas - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

Case builds for Biogen, Stoke's Dravet syndrome drug - pharmaphorum

Jul 11, 2025
pulisher
Jul 10, 2025

Biogen and Stoke Therapeutics Announce Presentation of Data from Studies of Zorevunersen, an Investigational Medicine for Dravet syndrome, at the 16th European Paediatric Neurology Society (EPNS) Congress - Ariva

Jul 10, 2025
pulisher
Jul 10, 2025

Biogen (BIIB) Presents Promising Data from Zorevunersen Studies - GuruFocus

Jul 10, 2025
pulisher
Jul 10, 2025

Stoke Therapeutics and Biogen Announce Presentation of Data from Studies of Zorevunersen, an Investigational Medicine for Dravet syndrome, at the 16th European Paediatric Neurology Society (EPNS) Congress - Business Wire

Jul 10, 2025
pulisher
Jul 09, 2025

Stoke Therapeutics Files $400 Million Mixed Shelf Offering - AInvest

Jul 09, 2025
pulisher
Jul 09, 2025

Stoke Therapeutics Files $400 Million Mixed Shelf - MarketScreener

Jul 09, 2025
pulisher
Jul 09, 2025

Stoke Therapeutics (STOK) Announces $400M Mixed Securities Shelf Registration | STOK Stock News - GuruFocus

Jul 09, 2025
pulisher
Jul 01, 2025

Stoke Therapeutics (STOK) Receives Continued 'Buy' Rating from N - GuruFocus

Jul 01, 2025
pulisher
Jun 30, 2025

Stoke Therapeutics, Inc. (NASDAQ:STOK) Receives Average Rating of “Buy” from Analysts - Defense World

Jun 30, 2025
pulisher
Jun 17, 2025

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | STOK Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Jun 17, 2025
pulisher
Jun 16, 2025

STOK FY2025 EPS Forecast Lowered by Cantor Fitzgerald - Defense World

Jun 16, 2025
pulisher
Jun 15, 2025

Stoke Therapeutics: Impressive Pipeline And Big Backers - Seeking Alpha

Jun 15, 2025
pulisher
Jun 15, 2025

Zorevunersen's Pivotal Moment: Why Stoke Therapeutics Offers Rare Disease Innovation at a Strategic Inflection Point - AInvest

Jun 15, 2025
pulisher
Jun 13, 2025

Stoke Therapeutics, Inc. (NASDAQ:STOK) Shares Acquired by California State Teachers Retirement System - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

FMR LLC Increases Stake in Stoke Therapeutics Inc: A Strategic M - GuruFocus

Jun 12, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Comments on STOK FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Encephalopathy Pipeline 2025: Comprehensive Clinical Trials - openPR.com

Jun 10, 2025
pulisher
Jun 10, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Stock Holdings in Stoke Therapeutics, Inc. (NASDAQ:STOK) - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

Stoke Therapeutics, Inc. (NASDAQ:STOK) Shares Sold by Two Sigma Investments LP - Defense World

Jun 09, 2025
pulisher
Jun 08, 2025

Ameriprise Financial Inc. Has $116,000 Stock Holdings in Stoke Therapeutics, Inc. (NASDAQ:STOK) - Defense World

Jun 08, 2025
pulisher
Jun 08, 2025

Jane Street Group LLC Sells 318,465 Shares of Stoke Therapeutics, Inc. (NASDAQ:STOK) - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

Stoke Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Updates - mx.advfn.com

Jun 07, 2025
pulisher
Jun 07, 2025

Millennium Management LLC Increases Position in Stoke Therapeutics, Inc. (NASDAQ:STOK) - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

(STOK) Technical Data - news.stocktradersdaily.com

Jun 06, 2025
pulisher
Jun 05, 2025

Stoke Therapeutics, Inc. (NASDAQ:STOK) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Insider Sell: Barry Ticho Sells 8,216 Shares of Stoke Therapeuti - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Insider Sell: Barry Ticho Sells 8,216 Shares of Stoke Therapeutics Inc (STOK) - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Stoke Therapeutics Adopts Key Proposals at Annual Meeting - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

BNP Paribas Financial Markets Trims Holdings in Stoke Therapeutics, Inc. (NASDAQ:STOK) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

ProShare Advisors LLC Acquires Shares of 12,626 Stoke Therapeutics, Inc. (NASDAQ:STOK) - Defense World

Jun 03, 2025
pulisher
May 31, 2025

Contrasting Stoke Therapeutics (NASDAQ:STOK) & Renovaro (NASDAQ:RENB) - Defense World

May 31, 2025
pulisher
May 29, 2025

Stoke Therapeutics to Present at the 2025 Jefferies Global Healthcare Conference - BioSpace

May 29, 2025
pulisher
May 29, 2025

Stoke Therapeutics to Present at the Jefferies Global Healthcare Conference | STOK Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Stoke Therapeutics to Present at the Jefferies Global Healthcare Conference - Business Wire

May 29, 2025
pulisher
May 28, 2025

D. E. Shaw & Co. Inc. Sells 143,203 Shares of Stoke Therapeutics, Inc. (NASDAQ:STOK) - Defense World

May 28, 2025
pulisher
May 26, 2025

How to Take Advantage of moves in (STOK) - news.stocktradersdaily.com

May 26, 2025
pulisher
May 23, 2025

Northern Trust Corp Purchases 11,635 Shares of Stoke Therapeutics, Inc. (NASDAQ:STOK) - Defense World

May 23, 2025
pulisher
May 20, 2025

Stoke Therapeutics, Inc.'s (NASDAQ:STOK) Shares Bounce 28% But Its Business Still Trails The Industry - simplywall.st

May 20, 2025
pulisher
May 19, 2025

Chardan Capital Has Strong Forecast for STOK FY2025 Earnings - Defense World

May 19, 2025
pulisher
May 18, 2025

Analysts Issue Forecasts for STOK FY2026 Earnings - Defense World

May 18, 2025
pulisher
May 18, 2025

Research Analysts Issue Forecasts for STOK FY2025 Earnings - Defense World

May 18, 2025
pulisher
May 17, 2025

Wall Street Analysts Think Stoke Therapeutics (STOK) Could Surge 132.4%: Read This Before Placing a Bet - MSN

May 17, 2025
pulisher
May 17, 2025

HC Wainwright Analysts Decrease Earnings Estimates for STOK - Defense World

May 17, 2025
pulisher
May 17, 2025

Q2 EPS Estimates for Stoke Therapeutics Raised by Wedbush - Defense World

May 17, 2025
$21.87
price up icon 3.40%
$35.60
price down icon 2.49%
$104.59
price up icon 1.67%
$28.27
price up icon 16.05%
$112.49
price up icon 1.66%
biotechnology ONC
$279.16
price up icon 3.51%
Capitalizzazione:     |  Volume (24 ore):